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Abstract
Introduction: The Department of Health and Human Services’ 2010 Strategic Framework on Multiple Chronic
Conditions called for the identification of common constellations of conditions in older adults. Objectives: To
analyze patterns of conditions constituting multimorbidity (CCMM) and expenditures in a US representative
sample of midlife and older adults (50–64 and ≥65 years of age, respectively). Design: A cross-sectional study
of the 2010 Health and Retirement Study (HRS; n=17,912). The following measures were used: (1) count and
combinations of CCMM, including (i) chronic conditions (hypertension, arthritis, heart disease, lung disease,
stroke, diabetes, cancer, and psychiatric conditions), (ii) functional limitations (upper body limitations, lower
body limitations, strength limitations, limitations in activities of daily living, and limitations in instrumental
activities of daily living), and (iii) geriatric syndromes (cognitive impairment, depressive symptoms, incontinence, visual impairment, hearing impairment, severe pain, and dizziness); and (2) annualized 2011 Medicare
expenditures for HRS participants who were Medicare fee-for-service beneficiaries (n=5,677). Medicaid beneficiaries were also identified based on their self-reported insurance status. Results: No large representations of
participants within specific CCMM categories were observed; however, functional limitations and geriatric syndromes were prominently present with higher CCMM counts. Among fee-for-service Medicare beneficiaries
aged 50–64 years, 26.7% of the participants presented with ≥10 CCMM, but incurred 48% of the expenditure.
In those aged ≥65 years, these percentages were 16.9% and 34.4%, respectively. Conclusion: Functional limitations and geriatric syndromes considerably add to the MM burden in midlife and older adults. This burden is
much higher than previously reported.
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Introduction
In 2011, nearly two thirds of Medicare fee-for-service
(FFS) beneficiaries had two or more chronic conditions, and 15% presented with six or more chronic
conditions [1]. In addition, the average annual Medicare expenditures for beneficiaries with six or more
chronic conditions was approximately threefold that of
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beneficiaries with four or five conditions (USD 31,543
vs. USD 11,628) [1].
The co-occurrence of multiple chronic conditions
with functional limitations [2–10] and geriatric syndromes [11–14] has been well documented. In parallel,
the shared risk factors between geriatric syndromes and
functional dependence have also been described. In a
1995 study, Tinetti et al. [15] showed that decreased
upper extremity impairment, decreased lower body
impairment, sensory impairment, and affective impairment were predisposing factors for incontinence, falls,
and functional dependence. Moreover, cognitive
impairment has been shown to be associated with disability [16,17] and limitations in instrumental activities
of daily living [18]. Extending the intricate association
between geriatric syndromes and functional dependence to that of chronic conditions, Martinez et al. [19]
demonstrated that both chronic obstructive pulmonary
disease and mild cognitive impairment increased the risk
of disability.
Building on the above line of inquiry, we have
adopted a more encompassing definition of multimorbidity (MM) by accounting for functional limitations
and geriatric syndromes, rather than chronic conditions
alone, thus drawing a clear distinction between MM and
multiple chronic conditions. We have also shown that
the co-occurrence of functional limitations and geriatric syndromes with chronic conditions is (i) highly
prevalent in older adults, and (ii) has cumulative effects
relative to health outcomes [20], thus reflecting greater
disease burden. Such an encompassing approach is all
the more relevant with the aging of the population,
given that the findings will guide future developments
in clinical care, research methodology, and healthcare
policy. This is best reflected through the Department of
Health and Human Services’ 2010 Strategic Framework
on Multiple Chronic Conditions [21], which calls for
studies to “understand the epidemiology of multiple chronic
conditions” (Goal 4, Objective B), while highlighting the
limited research about “the constellations of conditions that
are most prevalent and most important in terms of disability
among individuals with MCC.” This document further
calls for additional research identifying the “most common patterns of MCC,” which can help in “targeting specific
interventions for specific subgroups and monitoring the impact of
those interventions.”
In the present study, we use rich survey data from the
Health and Retirement Study (HRS) on a US representative sample of midlife and older adults to analyze the
number of chronic conditions, functional limitations,
and geriatric syndromes constituting MM across sociodemographic strata. We build upon our previous work
[20] in two key ways. First, we provide a more detailed
characterization of the profile of MM in midlife and

older adults. Rather than examining the co-occurrence
of chronic conditions, functional limitations, and geriatric syndromes in broad terms, we report on the most
frequently co-occurring specific conditions constituting
MM (CCMM). Second, in a subset of the study population receiving care through the Medicare FFS system,
we analyze the number of CCMM in relation to Medicare expenditures. Given potential differences between
younger (50–64 years of age) and older (≥65 years of
age) Medicare beneficiaries in their MM patterns and
expenditures, we conducted these analyses after stratifying the data by age.
The study hypotheses were: (i) older age is associated
with a greater count of CCMM; (ii) a greater count of
CCMM is associated with higher expenditures; (iii) a
relatively smaller percentage of Medicare beneficiaries
with a high count of CCMM incur a high percentage
of Medicare expenditures; and (iv) rather than a large
representation of HRS participants with specific combinations of CCMM, there are certain conditions, or
combinations of conditions, that appear frequently with
greater counts of CCMM.
Objectives
The objectives of this study were to analyze patterns of
CCMM and expenditures in a US representative sample
of midlife and older adults (50–64 and ≥65 years of age,
respectively).
Methods
A cross-sectional study was performed using data from
the 2010 HRS and linked Medicare data from 2010
to 2011. The study was approved by the University of
Michigan, which administers the HRS; the Centers for
Medicare & Medicaid Services (CMS) privacy board;
and the Institutional Review Board at Case Western
Reserve University.
Data sources
The HRS

Launched in 1992, and supported by the National Institute on Aging, the HRS is a biennial survey of US
representative sample of adults aged 50 years or older.
To date, approximately 30,000 older adults have been
surveyed by the HRS. In addition to sociodemographic
variables, the HRS includes a broad range of variables on
self-reported chronic conditions, functional status, cognitive status, and depressive symptoms, among others.
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The Medicare beneficiary summary file (MBSF)

Individuals who agree to have their HRS survey data
linked to their Medicare records can also be identified in
Medicare administrative files. Thus, the MBSF was used
to retrieve relevant data for HRS respondents who were
Medicare beneficiaries, including those who enrolled in
Medicare before age-qualifying for the program. The
MBSF carries monthly variables indicating beneficiaries’ enrollment in Medicare managed care programs,
making it possible to identify Medicare beneficiaries
receiving care through the traditional system. The
MBSF also includes the total Medicare expenditures
incurred by FFS beneficiaries during a given calendar
year. Thus, the MBSF was used to identify Medicare
FFS beneficiaries and to analyze expenditures relative to
the count of CCMM identified from the HRS.
The linked HRS–MBSF file

This cross-reference file, which is made available to
researchers when accessing the restricted linked HRS–
MBSF files, enables portions of the records from each
of the HRS and MBSF to be linked and to construct a
unique record for each individual in the study population.
Study population

A total of 18,005 individuals were surveyed in 2010.
This did not include proxy respondents or former HRS
participants who died prior to the 2010 scheduled interview. Records for individuals with missing data on study
variables (n=93) were excluded, leaving a total of 17,912
in the study population.
As noted above, Medicare data were obtained from
the MBSF for 5,677 individuals (n=648 for 50–64-year
olds and n=5,029 for ≥65-year olds) who were enrolled
in Medicare, regardless of their age, and who had
received their care services through the FFS program.
Key variables of interest
Multimorbidity

Variables included in our definition of MM were not
only self-reported chronic conditions but also functional
limitations and geriatric syndromes. The following
specific conditions were accounted for in each of the
aforementioned broad rubrics:
•• Self-reported chronic conditions (possible total count
of eight), indicating whether the individual was ever
told by a physician that he or she had hypertension,
arthritis, heart disease, lung disease, non-skin cancer,
stroke, diabetes, and psychiatric conditions.
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•• Functional limitations (possible count of five): upper
body limitations (e.g. difficulty picking up a coin from
the floor or reaching overhead); lower body limitations
(e.g. difficulty climbing stairs or walking around the
block); strength limitations (e.g. ability to lift 4.5 kg or
difficulty in moving a large object); limitations in activities of daily living (ADL; e.g. crossing a room, dressing,
bathing); and limitations in instrumental ADL (IADL;
e.g. ability to prepare meals or manage money).
•• Geriatric syndromes (possible count of seven): poor
cognitive functioning (lowest tertile of cognitive
score obtained from the Telephone Interview Cognitive Survey [TIC]); depressive symptoms (answered
“yes” to at least four of the eight items of the Center
for Epidemiological Studies-Depression [CES-D]
scale); visual impairment; hearing impairment; often
experience severe pain; incontinence; and dizziness.
Thus, the total count of conditions that an individual
may potentially present with is 20.
Annualized median Medicare expenditures

The MBSF includes the total amount of Medicare expenditure incurred by a beneficiary in a given year. To account
for partial-year enrollment caused by entering mid-year
or exiting the program (mainly through death), we calculated the per-person per month (PPPM) expenditures
by aggregating the Medicare expenditures in 2010 and
2011, and dividing the total amount by the total number
of FFS months during the 2-year period. To obtain more
robust estimates, we calculated the PPPM based on 2-year
rather than 1-year data. To annualize, we then multiplied
the PPPM expenditures by 12, and afterwards by 0.01 to
account for inflation from 2010 to 2011. Data are presented
as median to address the skewedness of expenditures.
Other variables of interest

Other data retrieved from the HRS included age (<64,
65–74, 75–74, and ≥85 years); sex; race (Non-Hispanic
White, Non-Hispanic Black, Hispanic, and other); marital status (married and non-married); years of education
(<9, 9–11, 12, 13–15, 16, and ≥17); income (<100% of
the federal poverty level, 100–199%, 200–299%, and
≥300%); and self-reported Medicaid receipt (yes/no).
Analysis

Using survey weights to account for the complex survey design of the HRS, we conducted a descriptive
analysis to identify patterns of CCMM count in the
sociodemographic strata of our study population and to
report the median annualized expenditures for CCMM.
To analyze the combinations of CCMM, we used two
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different approaches. First, we used association rule
mining (ARM) to identify the most common monads,
dyads, triads, quadriads, and pentads, and to determine
whether or not they co-occur with any other conditions.
ARM was developed in the realm of marketing research
to identify items that are commonly purchased together
and is now applied in a variety of settings, including
medicine and bioinformatics [22–24]. Second, we identified the five most frequently observed specific CCMM
that were identified in each of the count categories. For
parsimony, we limited our reporting of CCMM to the
top five most-frequently observed combinations. We
used R version 3.3.1 and “arules” package 1.4-1 for the
ARM analysis, and SAS version 9.3 for all other analyses.
Results
Of the 17,912 HRS participants included in our study,
about half (50.9%) were younger than 65 years of age,
42.7% were men, 31.3% were non-Hispanic Black
or Hispanic, 21% had less than 12 years of education,
32.3% had an income of less than 200% of the federal
poverty level, and 6.2% were on Medicaid or dually eligible Medicare–Medicaid beneficiaries (Table 1).
Only 15.6% of study participants presented with no
or only one condition, and 22.3% presented with two or
three conditions. The remaining 62% of the population
presented with at least four conditions, including 11.4%
with 10 or more conditions.
A higher count of conditions was observed among
older than younger individuals. For example, 7.4% of
individuals aged 50–64 years presented with 10 or more
conditions, compared with 31.8% of those aged ≥85
years. Similarly, higher counts were observed among
women than among men; among those with lower
income and/or educational attainment than among
those with higher income and/or educational attainment; and among those on Medicaid or dually eligible
Medicare–Medicaid beneficiaries (Table 1).
Our analysis of the combinations of conditions is
described below, and is as follows: first, we show the most
common combinations of conditions (monads, dyads, etc.)
that appear regardless of whether or not they co-occur
with other conditions (e.g. combination of hypertension and arthritis, with or without the co-occurrence
of strength limitations or incontinence); next, we show
the number of individuals with specific combinations of conditions, without the co-occurrence of other conditions;
and lastly, we present results showing the association
between the number of conditions with which individuals present and the Medicare expenditures.
The most common monads, dyads, triads, quadriads, and
pentads of combinations within CCMMs are shown in

Tables 2A (age 50–64 years) and 2B (age ≥65 years). The
conditions are color-shaded to highlight the frequency
with which certain conditions appear across the different count categories.
Among individuals aged 50–64 years, the most common condition was hypertension (50.0%), whether
presenting with or without the co-occurrence of any
other condition (Table 2A). The most common dyad
was limitations in lower body functioning and strength
limitations (37.2%). For triads, the most common conditions were hypertension, limitations in lower body
functioning, and strength limitations (24.0%). The most
common quadriad consisted of hypertension, arthritis,
limitations in lower body functioning, and strength limitations (16.4%). The most common pentad included the
aforementioned conditions, in addition to limitations in
upper body functioning (11.0%) (Table 2A).
Among individuals aged ≥65 years, the most frequent
monads, dyads, triads, quadriads, and pentads were
identical to those observed in the younger age group
(50–64 years), but the percent of individuals presenting with these combinations of conditions differed
markedly (Tables 2A and 2B). For example, 72.3% of
adults aged ≥65 years had hypertension compared with
50.0% of those in the younger age group, whether or
not hypertension co-occurred with any other condition.
Similarly, 25.3% of individuals aged ≥65 years presented
with the pentad of hypertension, arthritis, limitations in
upper body functioning, limitations in lower body functioning, and strength limitations, compared with only
11.0% of those in the younger age group. Interestingly,
the most common monad, dyad, quadriad, and pentad
appearing in combinations of conditions was identical
across the two age groups.
The percent of individuals presenting with the top
five most frequent combinations of CCMM is shown in
Tables 3A (age 50–64 years) and 3B (age ≥65 years). As
noted above, this analysis differs from the one presented
in Tables 2A and 2B in that it accounts for the exact
combinations of conditions with which individuals
present, without the co-occurrence of other conditions.
Again, for parsimony, only combinations up to a count
of five are shown.
In both age groups of the population, our analysis did
not show any large representations of HRS participants
with specific CCMM (Tables 3A and 3B). Rather, we
observed great heterogeneity in the grouping of individuals with specific combinations of CCMM. For
example, for individuals aged 50–64 years, the most
frequent CCMM for two conditions (hypertension
and poor cognition) accounted for only 96 of the 1,422
individuals (6.8%) presenting with two conditions
(Table 3A). Similarly, for individuals aged ≥65 years, the
most frequent CCMM for two conditions (hypertension
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Table 1 Distribution of the study population by sociodemographic characteristics and by number of conditions constituting multimorbidity.
Number of chronic conditions, functional limitations, and geriatric syndromes
N (% of total study
population)
Total population
17,912 (100.0)
Age, years
50–64
9,111 (50.9)
65–74
4,254 (23.7)
75–84
3,246 (18.1)
1,301 (7.3)
≥85
Sex
Male
7,640 (42.7)
Female
10,272 (57.3)
Race/ethnicity
 White Non11,770 (65.7)
Hispanic
 Black Non3,346 (18.7)
Hispanic
Hispanic
2,264 (12.6)
Other
532 (3.0)
Marital status
Married
7,250 (40.5)
Not married
10,662 (59.5)
Education, years
<9
1,696 (9.5)
9–11
2,068 (11.5)
12
5,638 (31.5)
13–15
4,256 (23.8)
16
2,210 (12.3)
2,044 (11.4)
≥17
Income as % of federal poverty level
<100
2,315 (12.9)
100–199
3,479 (19.4)
200–299
2,954 (16.5)
9,164 (51.2)
≥300
Medicaid status
No
16,796 (93.8)
Yes
1,116 (6.2)

0 or 1
N (%)

2 or 3
N (%)

4 or 5
N (%)

6 or 7
N (%)

8 or 9
N (%)

≥10
N (%)

2,802 (15.6)

4,000 (22.3)

3,743 (20.9)

3,200 (17.9)

2,129 (11.9)

2,038 (11.4)

2,285 (25.1)
391 (9.2)
112 (3.5)
14 (1.1)

2,554 (28.0)
929 (21.8)
443 (13.6)
74 (5.7)

1,751 (19.2)
1,086 (25.5)
734 (22.6)
172 (13.2)

1,170 (12.8)
938 (22.0)
808 (24.9)
284 (21.8)

680 (7.5)
499 (11.7)
607 (18.7)
343 (26.4)

671 (7.4)
411 (9.7)
542 (16.7)
414 (31.8)

1,439 (18.8)
1,363 (13.3)

1,897 (24.8)
2,103 (20.5)

1,610 (21.1)
2,133 (20.8)

1,262 (16.5)
1,938 (18.9)

765 (10.0)
1,364 (13.3)

667 (8.7)
1,371 (13.3)

1,881 (16.0)

2,621 (22.3)

2,544 (21.6)

2,138 (18.2)

1,388 (11.8)

1,198 (10.2)

439 (13.1)

706 (21.1)

683 (20.4)

601 (18.0)

413 (12.3)

504 (15.1)

356 (15.7)
126 (23.7)

524 (23.1)
149 (28.0)

434 (19.2)
82 (15.4)

379 (16.7)
82 (15.4)

280 (12.4)
48 (9.0)

291 (12.9)
45 (8.5)

822 (11.3)
1,980 (18.6)

1,339 (18.5)
2,661 (25.0)

1,382 (19.1)
2,361 (22.1)

1,377 (19.0)
1,823 (17.1)

1,090 (15.0)
1,039 (9.7)

1,240 (17.1)
798 (7.5)

98 (5.8)
133 (6.4)
700 (12.4)
752 (17.7)
579 (26.2)
540 (26.4)

249 (14.7)
298 (14.4)
1,178 (20.9)
1,044 (24.5)
642 (29.0)
589 (28.8)

296 (17.5)
408 (19.7)
1,224 (21.7)
944 (22.2)
438 (19.8)
433 (21.2)

339 (20.0)
447 (21.6)
1,172 (20.8)
702 (16.5)
278 (12.6)
262 (12.8)

306 (18.0)
376 (18.2)
717 (12.7)
432 (10.2)
167 (7.6)
131 (6.4)

408 (24.1)
406 (19.6)
647 (11.5)
382 (9.0)
106 (4.8)
89 (4.4)

183 (7.9)
269 (7.7)
333 (11.3)
2,017 (22.0)

355 (15.3)
514 (14.8)
590 (20.0)
2,541 (27.7)

447 (19.3)
643 (18.5)
638 (21.6)
2,015 (22.0)

416 (18.0)
769 (22.1)
617 (20.9)
1,398 (15.3)

376 (16.2)
625 (18.0)
427 (14.5)
701 (7.6)

538 (23.2)
659 (18.9)
349 (11.8)
492 (5.4)

2,784 (16.6)
18 (1.6)

3,935 (23.4)
65 (5.8)

3,598 (21.4)
145 (13.0)

2,995 (17.8)
205 (18.4)

1,872 (11.1)
257 (23.0)

1,612 (9.6)
426 (38.2)

and arthritis) accounted for 80 of the 620 individuals
(12.9%) presenting with this combination of conditions
(Table 3B). Of note, the combination of hypertension
and arthritis was also frequently observed in individuals
of both age groups with CCMM counts greater than
two. Moreover, we note the prominence of functional
limitations in these combinations of conditions, especially lower body limitations and strength limitations. In
particular, the combination of limitations in lower body
functioning and strength limitations begins to emerge
– and is consistently present – among individuals presenting with a CCMM count of three or greater.
Figure 1 shows expenditure data related to counts
of CCMM, stratified by age group. These analyses are
limited to HRS participants who are also Medicare
beneficiaries, and receive their care through the FFS
program; hence, the distribution of individuals by the
CCMM is different from that described above for all
HRS participants. The median annualized expenditures

increases considerably with the number of CCMM
with which individuals present. However, rather than
a straight line, the association is “J-shaped,” showing a
sharp increase in the expenditures with greater CCMM
counts.
The distribution of individuals and expenditures by
CCMM, and stratified by age, is shown in Figures 2A
and 2B. In individuals aged 50–64 years, 26.7% of the
participants presented with 10 or more CCMM, but
incurred almost half (48.2%) of the expenditures ( Figure
2A). In those aged ≥65 years, 17.0% presented with 10 or
more CCMM and incurred 34.4% of the expenditures
(Figure 2B).
Discussion
Using a unique resource combining survey and administrative data for a representative sample of US midlife and
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Table 2A Five most frequently observed monads, dyads, triads, quadriads, and pentads appearing in combinations of conditions constituting multimorbidity among adults aged 50–64 years.

Monads
Dyads

Limitations / Lower body
Hypertension
Hypertension
Arthritis
Arthritis

Limitations / Strength
Limitations / Lower body
Limitations / Strength
Limitations / Strength
Limitations / Lower body

Triads

Hypertension
Arthritis
Limitations / Upper body
Hypertension
Hypertension

Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Arthritis
Arthritis

Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Lower body
Limitations / Strength

Quadriads

Hypertension
Hypertension
Arthritis
Hypertension
Hypertension

Arthritis
Limitations / Lower body
Limitations / Lower body
Arthritis
Limitations / Lower body

Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Upper body

Limitations / Lower body
Limitations / Upper body
Limitations / Upper body
Limitations / Upper body
Diabetes

Pentads

N (% of total n=9,111)
Hypertension
Limitations / Strength
Limitations / Lower body
Arthritis
Limitations / Upper body

4,558 (50.0)
4,263 (46.8)
4,250 (46.6)
3,643 (40.0)
2,444 (26.8)

Hypertension
Hypertension
Arthritis
Hypertension
Hypertension

Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Limitations / Lower body

Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Strength

Limitations / Upper body
Limitations / Upper body
Limitations / Upper body
Limitations / Upper body
Limitations / Upper body

3,389 (37.2)
2,635 (28.9)
2,590 (28.4)
2,538 (27.9)
2,509 (27.5)
2,192 (24.0)
2,187 (24.0)
1,994 (21.9)
1,670 (18.3)
1,669 (18.3)
1,496 (16.4)
1,386 (15.5)
1,386 (15.2)
1,043 (11.5)
1,039 (11.4)
1,006 (11.0)
649 (7.1)
630 (6.9)
629 (6.9)
612 (6.7)

Arthritis
Impaired vision
Limitations / IADL
Limitations / IADL
Depressive Symptoms

IADL, instrumental activities of daily living.
Table 2B Five most frequently observed monads, dyads, triads, quadriads, and pentads appearing in combinations of conditions constituting multimorbidity among adults aged ≥65 years.

Monads
Dyads

Limitations / Lower body
Hypertension
Arthritis
Hypertension
Arthritis

Limitations / Strength
Limitations / Lower body
Limitations / Lower body
Arthritis
Limitations / Strength

Triads

Arthritis
Hypertension
Hypertension
Hypertension
Limitations / Lower body

Limitations / Lower body
Limitations / Lower body
Arthritis
Arthritis
Limitations / Upper body

Limitations / Strength
Limitations / Strength
Limitations / Lower body
Limitations / Strength
Limitations / Strength

Quadriads

Hypertension
Arthritis
Hypertension
Hypertension
Hypertension

Arthritis
Limitations / Upper body
Limitations / Upper body
Arthritis
Arthritis

Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Limitations / Upper body
Limitations / Upper body

Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Lower body
Limitations / Strength

Pentads

N (% of total n=8,801)
Hypertension
Limitations / Lower body
Arthritis
Limitations / Strength
Limitations / Upper body

6,367 (72.3)
6,201 (70.5)
6,085 (69.1)
5,844 (66.4)
3,807 (43.3)

Hypertension
Hypertension
Hypertension
Hypertension
Arthritis

Arthritis
Arthritis
Arthritis
Limitations / Upper body
Limitations / Upper body

Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Limitations / Lower body

Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Strength

5,058 (57.5)
4,786 (54.4)
4,784 (54.4)
4,626 (52.6)
4,590 (52.2)
4,074 (46.3)
3,956 (45.0)
3,784 (43.0)
3,626 (41.2)
3,227 (36.7)
3,262 (37.1)
2,676 (30.4)
2,627 (29.8)
2,372 (27.0)
2,328 (26.5)
Limitations / Upper body
Heart disease
Poor cognition
Heart disease
Heart disease

2,228 (25.3)
1,604 (18.3)
1,390 (15.8)
1,384 (15.7)
1,356 (15.4)
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Table 3A Most frequent combinations of conditions constituting multimorbidity among adults aged 50–64 years, by number of conditions (top five only).

1 Condition
2 Conditions

Hypertension
Hypertension
Hypertension
Limitations / Lower body
Hypertension

Poor cognition
Arthritis
Diabetes
Limitations / Strength
Limitations / Lower body

3 Conditions

Arthritis
Hypertension
Hypertension
Hypertension
Hypertension

Limitations / Lower body
Limitations / Lower body
Arthritis
Arthritis
Arthritis

Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Lower body
Diabetes

4 Conditions

Hypertension
Arthritis
Hypertension
Hypertension
Arthritis

Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Limitations / Lower body

Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Strength

Arthritis
Limitations / Upper body
Limitations / Upper body
Impaired vision
Poor cognition

5 Conditions

N (%) N (% of total n=9,111)
389 (27.8)
173 (12.3)
1,401 (15.4)
162 (11.6)
93 (6.6)
92 (6.6)

Hypertension
Poor cognition
Arthritis
Impaired vision
Incontinence

Hypertension
Hypertension
Hypertension
Hypertension
Hypertension

Arthritis
Arthritis
Arthritis
Arthritis
Arthritis

Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Limitations / Lower body

Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Strength

Limitations / Upper body
Diabetes
Poor cognition
Incontinence
Cancer

96 (6.8)
94 (6.6)
91 (6.4)
73 (5.1)
61 (4.3)

1,422 (15.6)

59 (5.2)
53 (4.7)
46 (4.1)
27 (2.4)
23 (2.0)

1,132 (12.4)

84 (8.4)
37 (3.7)
21 (2.1)
16 (1.6)
15 (1.5)

995 (10.9)

34 (4.5)
33 (4.4)
14 (1.9)
11 (1.5)
11 (1.5)

756 (8.3)

Table 3B Most frequent combinations of conditions constituting multimorbidity among adults aged ≥65 years, by number of conditions (top five only).

1 Condition
2 Conditions

Hypertension
Hypertension
Hypertension
Arthritis
Arthritis

Arthritis
Heart disease
Poor cognition
Incontinence
Limitations / Lower body

3 Conditions

Arthritis
Hypertension
Hypertension
Hypertension
Hypertension

Limitations / Lower body
Arthritis
Arthritis
Arthritis
Arthritis

Limitations / Strength
Limitations / Strength
Limitations / Lower body
Heart Disease
Poor Cognition

4 Conditions

Hypertension
Arthritis
Arthritis
Hypertension
Arthritis

Arthritis
Limitations / Upper body
Limitations / Upper body
Arthritis
Limitations / Lower body

Limitations / Lower body
Limitations / Lower body
Limitations / Strength
Limitations / Strength
Limitations / Strength

Limitations / Strength
Limitations / Strength
Incontinence
Cancer
Poor cognition

5 Conditions

N (%) N (% of total n=8,801)
120 (32.1)
65 (17.4)
374 (4.2)
40 (10.7)
29 (7.8)
21 (5.6)

Hypertension
Arthritis
Poor cognition
Cancer
Heart Disease

Hypertension
Hypertension
Hypertension
Hypertension
Hypertension

Arthritis
Arthritis
Arthritis
Arthritis
Arthritis

Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Limitations / Lower body
Limitations / Lower body

Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Strength
Limitations / Strength

older adults, we evaluated the MM burden by examining the count of CCMM across sociodemographic strata,
as well as in terms of Medicare expenditures. We conducted this analysis using data for all HRS participants,

Limitations / Upper body
Incontinence
Poor cognition
Heart disease
Diabetes

80 (12.9)
36 (5.8)
35 (5.6)
31 (5.0)
25 (4.0)

620 (7.0)

51 (6.2)
47 (5.7)
39 (4.7)
27 (3.3)
22 (2.7)

826 (9.4)

101 (10.6)
20 (2.1)
17 (1.8)
16 (1.7)
14 (1.5)

950 (10.8)

60 (5.8)
36 (3.5)
34 (3.3)
34 (3.3)
23 (2.2)

1,042 (11.8)

as well as on the subset of HRS participants who are also
Medicare FFS beneficiaries. Our findings indicate that
functional limitations and geriatric syndromes considerably add to the MM burden in midlife and older adults,
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Figure 1 Median annualized expenditures by total number of conditions constituting multimorbidity, stratified by age (Medicare fee-for-service
beneficiaries only).
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Figure 2 Distribution of individuals (Medicare fee-for-service beneficiaries only) and expenditures by total number of conditions constituting
multimorbidity: (A) age 50–64 years (n=648), (B) age ≥65 years (n=5,029).

and that expenditures increase sharply with higher
counts of CCMM.
The disproportionate consumption of Medicare
expenditure by individuals with multiple chronic
conditions has been reported previously, though the
extent of the disproportionality varies across different
sources [25–27]. In a Robert Wood Johnson Foundation chartbook, Anderson reported that two thirds of
the Medicare expenditure is incurred by individuals
with five or more chronic conditions [25], while data
from the CMS indicate that 15% of Medicare FFS beneficiaries present with six or more chronic conditions, but
incur 51% of the Medicare expenditures [26]. While our
measures are not directly comparable to the ones used
in the aforementioned reports, we note that by incorporating functional limitations and geriatric syndromes
in our count of CCMM, we demonstrate a considerably
greater burden associated with MM: among Medicare

beneficiaries aged 50–64 years, 68% presented with
six or more CCMM and incurred 83% of the Medicare expenditures. Among beneficiaries aged ≥65 years,
these percentages were 58% and 79%, respectively. Our
findings show that a greater count of CCMM is associated with higher expenditures, possibly as a result of
co-occurring functional limitations and geriatric syndromes. The contribution of functional limitations to
higher expenditure is supported by our more recent
study [28] in which 64% of individuals aged ≥65 years
with self-rated poor health, as well as limitations in ADL
and IADL, incurred expenditures in the top quartile,
highlighting the importance of functional limitations in
explaining resource use. We note, however, that in our
current study, even our statistics may underestimate the
burden of MM, given that we limited our list of chronic
conditions to the eight self-reported in the HRS. The
burden would be considerably higher if our algorithm
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relied on a broader range of chronic conditions identified from claims data.
Despite the difference in the study measures, the
high burden of MM shown in our current analysis is
somewhat consistent with a report by the Agency for
Healthcare Research and Quality (AHRQ), indicating
that 80% of individuals aged ≥65 years have multiple
chronic conditions [27], using data from the Medical
Expenditure Panel Survey, and Hwang’s definition of
chronic condition as “one that lasted or was expected to last
twelve or more months and resulted in functional limitations,
and/or the need for ongoing medical care” [29]. Data from the
AHRQ report also indicate that 45% of individuals with
multiple chronic conditions have functional limitations,
including ADL, IADL, as well as any functional, activity, or sensory limitations [28].
Our results are also comparable to that of a recent study
by McClintock et al. [30] who assessed population health
based on a Comprehensive Model, which, in contrast to the
Medical Model, incorporates elements of health as defined
by the World Health Organization (e.g. mental health).
Using data from the National Social Life, Health, and
Aging Project, and latent class analysis, the Comprehensive
Model identified six health classes, including two classes, in
which mental health (loneliness), hearing impairment, and
bone fractures emerged as important conditions in defining
vulnerable health classes. In addition, whereas the Medical
Model grouped two thirds of the population into “robust
health” classes, the Comprehensive Model classified half
of the population as having significant vulnerabilities that
would impact their health outcomes.
Regarding CCMM, our findings failed to identify
large groups of individuals with specific combinations
of CCMMs (Tables 3A and 3B), but did identify combinations of CCMMs that co-occur frequently (Tables 2A
and 2B). This attests to the heterogeneity of individuals
with MM or multiple chronic conditions, as reported
by Whitson et al. [31]. A notable finding, however, is
that in individuals with two or more CCMM, we begin
observing the prominence of functional limitations and
geriatric syndromes. In particular, functional limitations
are almost always present in individuals presenting with
three or more CCMM. In addition, the combination of
limitations of lower body functioning and strength limitations are the most frequently observed dyad, regardless
of whether they co-occur with other conditions, presenting in 37.2% of individuals aged 50–64 years of age,
and in 57.5% of individuals aged ≥65 years.
These results have important implications both in
research and in clinical practice, warranting a shift of paradigm to account for functional limitations and geriatric
syndromes when studying MM and not simply focusing
on chronic conditions. In addition to being closely inter-
related [32–35], the former conditions also have important
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implications relative to health and healthcare outcomes
[36–40], health services utilization, including hospitalizations and readmissions [41,42], as well as to clinical practice
and healthcare policy. First, we believe that these data
strongly support the notion that MM in midlife and older
adults is the norm, rather than the exception, and – given
the heterogeneous combinations of the various conditions that we identify – that the care they receive must be
person-centered, rather than disease/condition-centered.
Second, our findings call for the wide adoption of such
instruments as the Comprehensive Geriatric Assessment
[43] to routinely evaluate patients’ physical, mental, affective, and sensory functioning, and to identify subgroups of
the midlife and older adults who are most vulnerable to
experience adverse outcomes. Similarly, these findings call
for the expansion and broader adoption of such programs
as Independence at Home [44], authorized by the Affordable
Care Act to provide primary care home visits to individuals
with multiple chronic conditions and functional limitations. This demonstration program, aimed at improving
patient and caregiver satisfaction and reducing the need
for hospitalization, has yielded savings of over USD 1,000
per beneficiary [44]. However, it is important that such
programs also place emphasis on geriatric syndromes for
eligibility criteria. By doing so, the program would have a
considerably greater impact relative to prevention as well.
For example, poor cognitive performance alone may not
qualify an individual for such a program; yet, it is listed as
one of the most frequent conditions, and part of the most
common dyads that also includes hypertension. Based on
the circular association between chronic conditions and
geriatric syndromes described earlier, a person with hypertension who also has cognitive impairment is likely to
suffer poor self-management, therefore poor blood pressure
control and complications. Finally, our findings call for the
availability of multidisciplinary care teams, and healthcare providers who can help community-dwelling midlife
and older adults, not only with the management of their
chronic conditions but also with their functional, cognitive, and sensory impairments. Such assistance may be
paramount to helping individuals stay at home and delay,
or even prevent institutionalization.
Findings from this study also have implications
regarding MM burden in midlife adults. Indeed, as
shown in Table 1, nearly 28% of those aged 50–64 years
have ≥6 CCMMs. These statistics inform us of the anticipated MM burden in incoming cohorts of Medicare
beneficiaries.
In conclusion, the prominence of co-occurring functional limitations and geriatric syndromes in CCMMs
provides a basis for developing clinical systems that consider the interaction among co-existing conditions and
treatments, and the needed resource allocation. Studies
on MM bear increasingly greater significance, especially
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given the aging of the population, as their findings will
guide future developments in clinical care for older
adults, research methodology, and policy analysis.
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